We found significantly less Calpain activity in CML versus control bone marrow cells (p<0.0001, n=3), but this difference was almost completely reversed by either C463S-Shp2 or DN-Gas2. The gene discussed is GAS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.